Risks Associated With the Non-Medicinal Use of Cannabis

被引:77
|
作者
Hoch, Eva [1 ]
Bonnet, Udo [2 ]
Thomasius, Rainer [3 ]
Ganzer, Florian [3 ]
Havemann-Reinecke, Ursula [4 ,5 ,6 ]
Preuss, Ulrich W. [7 ,8 ]
机构
[1] Heidelberg Univ, Dept Addict Behav & Addict Med, Cent Inst Mental Hlth, D-69115 Heidelberg, Germany
[2] Univ Duisburg Essen, Dept Psychiat Psychotherapy & Psychosomat Med, Evangel Krankenhaus Castrop Rauxel, Teaching Hosp, Essen, Germany
[3] Univ Hosp Hamburg Eppendorf, German Ctr Addict Res Childhood & Adolescence DZS, Hamburg, Germany
[4] Univ Gottingen, Dept Psychiat & Psychotherapy, Fac Med, Gottingen, Germany
[5] Univ Med Ctr Gottingen, DFG Res Ctr, Gottingen, Germany
[6] Univ Med Ctr Gottingen, Cluster Excellence Nanoscale Microscopy & Mol Phy, Gottingen, Germany
[7] Kreiskrankenhaus Prignitz, Dept Psychiat Psychotherapy & Psychosomat Med, Perleberg, Germany
[8] Univ Halle Wittenberg, Dept Psychiat Psychotherapy & Psychosomat Med, D-06108 Halle, Saale, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2015年 / 112卷 / 16期
关键词
USE DISORDERS; SUICIDAL BEHAVIORS; TREATMENT PROGRAM; BIPOLAR DISORDER; MARIJUANA USE; LUNG-CANCER; WITHDRAWAL; SMOKING; INTERVENTIONS; ABSTINENCE;
D O I
10.3238/arztebl.2015.0271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cannabis is the most commonly consumed illicit drug around the world; in Germany, about 4.5% of all adults use it each year. Intense cannabis use is associated with health risks. Evidence-based treatments are available for health problems caused by cannabis use. Methods: Selective literature review based on a search of the PubMed database, with special emphasis on systematic reviews, meta-analyses, cohort studies, randomized controlled trials (RCTs), case-control studies, and treatment guidelines. Results: The delta-9-tetrahydrocannabinol content of cannabis products is rising around the world as a result of plant breeding, while cannabidiol, in contrast, is often no longer detectable. Various medical conditions can arise acutely after cannabis use, depending on the user's age, dose, frequency, mode and situation of use, and individual disposition; these include panic attacks, psychotic symptoms, deficient attention, impaired concentration, motor incoordination, and nausea. In particular, intense use of high doses of cannabis over many years, and the initiation of cannabis use in adolescence, can be associated with substance dependence (DSM-5; ICD-10), specific withdrawal symptoms, cognitive impairment, affective disorders, psychosis, anxiety disorders, and physical disease outside the brain (mainly respiratory and cardiovascular conditions). At present, the most effective way to treat cannabis dependence involves a combination of motivational encouragement, cognitive behavioral therapy, and contingency management (level 1a evidence). For adolescents, family therapy is also recommended (level 1a evidence). No pharmacological treatments can be recommended to date, as evidence for their efficacy is lacking. Conclusion: Further research is needed to elucidate the causal relationships between intense cannabis use and potential damage to physical and mental health. Health problems due to cannabis use can be effectively treated.
引用
收藏
页码:271 / +
页数:12
相关论文
共 50 条
  • [1] Implications of the 2018 Canadian Cannabis Act: Should regulation differ for medicinal and non-medicinal cannabis use?
    Cox, Chelsea
    HEALTH POLICY, 2021, 125 (01) : 12 - 16
  • [2] The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings
    Lorenzetti, Valentina
    Hindocha, Chandni
    Petrilli, Kat
    Griffiths, Paul
    Brown, Jamie
    Castillo-Carniglia, Alvaro
    Caulkins, Jonathan P.
    Englund, Amir
    ElSohly, Mahmoud A.
    Gage, Suzanne H.
    Groshkova, Teodora
    Gual, Antoni
    Hammond, David
    Lawn, Will
    Lopez-Pelayo, Hugo
    Manthey, Jakob
    Mokrysz, Claire
    Pacula, Rosalie Liccardo
    van Laar, Margriet
    Vandrey, Ryan
    Wadsworth, Elle
    Winstock, Adam
    Hall, Wayne
    Curran, H. Valerie
    Freeman, Tom P.
    ADDICTION, 2022, 117 (06) : 1523 - 1525
  • [3] HOSPITAL ADMISSIONS FOR VOMITING AMONG PREGNANT WOMEN WHO SELF-REPORTED NON-MEDICINAL CANNABIS USE
    Qian, Siyu
    Seddon, Sarah
    DRUG AND ALCOHOL REVIEW, 2021, 40 : S121 - S121
  • [4] Non-medicinal therapeutics in psychiatry
    Szekely, D.
    Polosan, M.
    ANNALES MEDICO-PSYCHOLOGIQUES, 2010, 168 (07): : 546 - 551
  • [5] Regulatory imbalance between medicinal and non-medicinal nicotine
    Sweanor, D
    ADDICTION, 2000, 95 : S25 - S28
  • [6] PREVENTION AND NON-MEDICINAL TREATMENT OF HYPERTENSION
    SKRABAL, F
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1981, 123 (47): : 1791 - 1794
  • [7] Investigation of polysaccharide composition in medicinal and non-medicinal aloes
    Ahl, L. I.
    Pedersen, H. L.
    Willats, W. G. T.
    Ronsted, N.
    Grace, O. M.
    PLANTA MEDICA, 2016, 82
  • [8] Non-medicinal care of rare diseases
    Sarda, Pierre
    PRESSE MEDICALE, 2012, 41 : S12 - S14
  • [9] Non-medicinal management of fatigue associated with critical illness: a systematic review of the literature
    Elyn, Antoine
    MEDECINE PALLIATIVE, 2021, 20 (06): : 358 - 359
  • [10] PSYCHOACTIVE MEDICINAL AND NON-MEDICINAL DRUG-USE AMONG HIGH-SCHOOL-STUDENTS
    ROUSH, GC
    THOMPSON, WD
    BERBERIAN, RM
    PEDIATRICS, 1980, 66 (05) : 709 - 715